Article Text

PDF
Do mutations of the Pendred syndrome gene, SLC26A4, confer resistance to asthma and hypertension?
  1. A C Madeo1,2,
  2. A Manichaikul3,
  3. S P Pryor2,
  4. A J Griffith2
  1. 1
    National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland USA
  2. 2
    National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, Maryland USA
  3. 3
    Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA
  1. A J Griffith, National Institutes of Health, 5 Research Court, Rockville, Maryland 20850-3320, USA; griffita{at}nidcd.nih.gov

Abstract

Background and aims: Mutations of SLC26A4 cause Pendred syndrome, an autosomal recessive disorder comprising goitre and deafness with enlarged vestibular aqueducts (EVA). Recent studies in mouse models implicate Slc26a4 in the pathogenesis of asthma and hypertension. We hypothesise that asthma and hypertension are less prevalent among humans with SLC26A4 mutations.

Methods: We reviewed medical histories and SLC26A4 genotypes for 80 individuals with EVA and 130 of their unaffected family members enrolled in a study of EVA. We used Fisher’s exact test to compare the prevalence of asthma and hypertension among groups of subjects with zero, one, or two mutant alleles of SLC26A4.

Results: Although none of the 21 subjects with two mutant alleles of SLC26A4 had asthma or hypertension, there were no statistically significant differences in the prevalence of asthma or hypertension among subjects with zero, one, or two mutant alleles.

Conclusion: There might be a protective effect of SLC26A4 mutations for asthma and hypertension but our study is statistically underpowered to detect this effect. Study sizes of at least 1125 and 504 individuals will be needed for 80% power to detect an effect at α = 0.05 for asthma and hypertension, respectively. Our hypothesis merits a larger study since it has implications for potential strategies to treat hearing loss by manipulating SLC26A4 expression or function.

Statistics from Altmetric.com

Footnotes

  • Funding: We are supported by NIH intramural research funds Z01-DC000060 and Z01-DC000064 and the Intramural Research Program of the National Human Genome Research Institute.

  • Competing interests: None.

  • Patient consent: Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.